IKONISYS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.43 EUR | 0.00% |
|
0.00% | -8.33% |
| Feb. 19 | Ikonisys Says Hospitex Wins Italian Tender for Diagnostic Systems | MT |
| Jan. 02 | Ikonisys: production record for Hospitex | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Ikonisys S.A. is specialized in the design, manufacture and marketing of medical diagnostic equipment. The company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing. Net sales break down by source of revenue as follows:
- sales of products (65.3%): sales of Ikoniscope instruments and the related software application;
- sales of maintenance services (34.7%).
Calendar
2024-04-28
- Q4 2023 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.43
EUR
Average target price
6.3
EUR
Spread / Average Target
+340.56%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.33% | 15.96M | |
| +1.69% | 12.8B | |
| -7.57% | 7.61B | |
| +3.22% | 5.41B | |
| +0.93% | 4.51B | |
| +9.73% | 4.49B | |
| +9.21% | 2.73B | |
| -13.87% | 2.02B | |
| -11.63% | 1.73B | |
| +0.55% | 1.64B |
- Stock Market
- Equities
- ALIKO Stock
- News Ikonisys S.A.
- Ikonisys Signs Distribution Deal With Integrated Gulf Biosystems Group
